| DC Field | Value | Language |
|---|
| dc.contributor.author | Levchenkova, O. S. | - |
| dc.contributor.author | Vorobieva, V. V. | - |
| dc.contributor.author | Novikov, V. E. | - |
| dc.contributor.author | Legonkova, T. I. | - |
| dc.contributor.author | Volkova, E. N. | - |
| dc.date.accessioned | 2023-10-03T08:37:30Z | - |
| dc.date.available | 2023-10-03T08:37:30Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia / O.S. Levchenkova [et al.] // Research Results in Pharmacology. - 2023. - Vol.9, №1.-P. 49-59. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/56814 | - |
| dc.description.abstract | Thrombopoietin receptor agonists are commonly second-line drugs in immune thrombocytopenia (ITP) pharmacotherapy in children and prescribed for chronic ITP refractory to first-line therapy | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | immune thrombocytopenia | ru |
| dc.subject | thrombopoietin receptor agonists | ru |
| dc.subject | Romiplostim | ru |
| dc.subject | Eltrombopag | ru |
| dc.title | Thrombopoietin receptor agonists in pharmacotherapy of pediatric immune thrombocytopenia | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 1
|
